the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon
September 2011
Patients often don't realize the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon.
Patients on aspirin for secondary prevention...or on aspirin plus clopidogrel for acute coronary syndrome or after a stent...sometimes stop these drugs on their own with dire consequences.
For example, stopping aspirin in patients with a prior MI leads to 4 extra MIs per 1000 patients per year.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote